Qingtai Liang

State Key Laboratory Of Membrane Biology, China Ministry Of Education Key Laboratory Of Protein Sciences, Beijing Key Lab For Immunological Research On Chronic Diseases
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

A potent human neutralizing antibody targeting the receptor-binding site in the glycoprotein gp350 of Epstein-Barr virus.

A potent human neutralizing antibody targeting the receptor-binding site in the glycoprotein gp350 of Epstein-Barr virus.

Journal: Science China. Life sciences

Published: April 04, 2025

An IGHG1 variant exhibits polarized prevalence and confers enhanced IgG1 antibody responses against life-threatening organisms.

An IGHG1 variant exhibits polarized prevalence and confers enhanced IgG1 antibody responses against life-threatening organisms.

Journal: Nature immunology

Published: April 24, 2024

High recallability of memory B cells requires ZFP318-dependent transcriptional regulation of mitochondrial function.

High recallability of memory B cells requires ZFP318-dependent transcriptional regulation of mitochondrial function.

Journal: Immunity

Published: April 24, 2023

Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses.

Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses.

Journal: Nature communications

Published: August 03, 2022

RBD trimer mRNA vaccine elicits broad and protective immune responses against SARS-CoV-2 variants.

RBD trimer mRNA vaccine elicits broad and protective immune responses against SARS-CoV-2 variants.

Journal: iScience

Published: December 06, 2021

Loss of Spike N370 glycosylation as an important evolutionary event for the enhanced infectivity of SARS-CoV-2.

Loss of Spike N370 glycosylation as an important evolutionary event for the enhanced infectivity of SARS-CoV-2.

Journal: Cell research

Published: July 23, 2021

Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.

Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.

Journal: Frontiers in immunology

Published: April 21, 2021

Stabilized diverse HIV-1 envelope trimers for vaccine design.

Stabilized diverse HIV-1 envelope trimers for vaccine design.

Journal: Emerging microbes & infections

Published: April 04, 2020

A Single Substitution in gp41 Modulates the Neutralization Profile of SHIV during In Vivo Adaptation.

A Single Substitution in gp41 Modulates the Neutralization Profile of SHIV during In Vivo Adaptation.

Journal: Cell reports

Published: October 05, 2018

Showing 1-9 of 9

Last Updated: 09/26/2026